In Pain relief Naprosyn P 300mg/500mg Tablet gives relief from pain and swelling in the joints and muscles. Some of the conditions in which Naprosyn P 300mg/500mg Tablet can give you relief are rheumatoid arthritis, osteoarthritis, juvenile arthritis (a form of joint disease in children), gout, ankylosing spondylitis, low back pain, sprains, shoulder pain etc. It is also used to reduce fever and to relieve mild pain from headaches, muscle aches, menstrual periods, the common cold, toothaches, and backaches. It works by blocking your body's production of certain natural substances that cause pain, swelling and fever. Take the lowest dose of this medicine for the shortest time to control your symptoms or as prescribed by the doctor.
It is unsafe to consume alcohol with Naprosyn P 300mg/500mg Tablet.
Naprosyn P 300mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Naprosyn P 300mg/500mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
It is not known whether Naprosyn P 300mg/500mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Naprosyn P 300mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Naprosyn P 300mg/500mg Tablet may be needed. Please consult your doctor.
Naprosyn P 300mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Naprosyn P 300mg/500mg Tablet may be needed. Please consult your doctor. However, the use of Naprosyn P 300mg/500mg Tablet is not recommended in patients with severe liver disease and active liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More